Structure |
Chemical Name |
CAS |
MF |
![Cabozantinib impurity 4](/CAS/20210111/GIF/95932-39-1.gif) |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
![Rosuvastatin EP Impurity C](/CAS/20211123/GIF/1620823-61-1.gif) |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
![4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン](/CAS/20180527/GIF/1145671-52-8.gif) |
4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン |
1145671-52-8 |
C20H23N3O4 |
![(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate](/CAS/20180527/GIF/1052063-36-1.gif) |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
![4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate](/CAS/20180527/GIF/941296-96-4.gif) |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
![(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid](/CAS/20180629/GIF/CB13159054.gif) |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
![Amlodipine Impurity 10](/CAS/20180629/GIF/CB13159160.gif) |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
![Clopidogrel Impurity 8](/CAS/20180629/GIF/CB13159236.gif) |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
![Nilotinib genotoxic impurity 3](/CAS/20200611/GIF/915711-42-1.gif) |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
![Dapagliflozin Open Ring](/CAS/20200611/GIF/2100872-88-4.gif) |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
![Rortezide impurity](/) |
Rortezide impurity |
|
|
![Cabozantinib Impurity A](/) |
Cabozantinib Impurity A |
|
|
![Loxoprofen Impurity E](/) |
Loxoprofen Impurity E |
|
|
![(R)-4-Propylpyrrolidin-2-one](/CAS/20180527/GIF/930123-37-8.gif) |
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
![Rocuronium Bromide Intermediate B Impurity E-1](/CAS/20180808/GIF/1190105-60-2.gif) |
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
![4-Chloro-2-propylsulfanyl-pyrimidine](/CAS/20180527/GIF/1351990-36-7.gif) |
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
![benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate](/CAS/20200611/GIF/1194550-67-8.gif) |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
![D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-](/CAS/20180528/GIF/119238-52-7.gif) |
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
![2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI)](/CAS/GIF/155102-96-8.gif) |
2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI) |
155102-96-8 |
C5H9NO4 |
![Bumetanide Impurity 24](/) |
Bumetanide Impurity 24 |
|
|
![Rocuronium Bromide Impurity 37、38、39](/) |
Rocuronium Bromide Impurity 37、38、39 |
|
|
![Ritonavir EP Impurity HIJ](/) |
Ritonavir EP Impurity HIJ |
|
|
![Crisaborole Impurity 42](/) |
Crisaborole Impurity 42 |
|
|
![Perospirone Impurity 26](/) |
Perospirone Impurity 26 |
|
|
![Paxlovid Impurity 15](/) |
Paxlovid Impurity 15 |
|
|
![3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide](/) |
3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
![Canagliflozin Impurity 84](/) |
Canagliflozin Impurity 84 |
|
|
![Fondaparinux sodium impurity 18](/) |
Fondaparinux sodium impurity 18 |
|
|
![Fondaparinux sodium impurity 13](/) |
Fondaparinux sodium impurity 13 |
|
|
![Lasmiditan Impurity 1](/) |
Lasmiditan Impurity 1 |
|
|
![(5R,6R)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one](/) |
(5R,6R)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one |
|
|
![Olodaterol Impurity 22](/) |
Olodaterol Impurity 22 |
|
|
![Olodaterol Impurity 25](/) |
Olodaterol Impurity 25 |
|
|
![32,43,50-Tricarboxy-cyanoco balamin](/) |
32,43,50-Tricarboxy-cyanoco balamin |
|
|
![2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI)](/CAS/20200119/GIF/145281-92-1.gif) |
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
![Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]-](/CAS/20180529/GIF/15026-80-9.gif) |
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
![L-Phenylalanine, N-L-leucyl-, methyl ester](/CAS/20180529/GIF/38155-18-9.gif) |
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
![2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸](/CAS/20180531/GIF/4818-85-3.gif) |
2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸 |
4818-85-3 |
C12H12N2O5S |
![2H-1,3-ベンゾジオキソール-4-オール](/CAS/20180531/GIF/69393-72-2.gif) |
2H-1,3-ベンゾジオキソール-4-オール |
69393-72-2 |
C7H6O3 |
![1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)-](/CAS/20180527/GIF/774582-60-4.gif) |
1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)- |
774582-60-4 |
C15H13BrN2O |
![2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide](/CAS/20180527/GIF/857570-37-7.gif) |
2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide |
857570-37-7 |
C14H22N2O |
![(S)‐1‐ベンジル‐3‐N‐BOC‐アミノピペリジン](/CAS/GIF/216854-24-9.gif) |
(S)‐1‐ベンジル‐3‐N‐BOC‐アミノピペリジン |
216854-24-9 |
C17H26N2O2 |
![(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20180527/GIF/1987887-92-2.gif) |
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1987887-92-2 |
C24H21N3O3 |
![1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one](/CAS/20180527/GIF/1971858-36-2.gif) |
1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one |
1971858-36-2 |
C23H25F3N4O |
![2-[3-(メチルアミノ)-1-(チオフェン-2-イル)プロピル]ナフタレン-1-オール](/CAS/20180527/GIF/1033803-59-6.gif) |
2-[3-(メチルアミノ)-1-(チオフェン-2-イル)プロピル]ナフタレン-1-オール |
1033803-59-6 |
C18H19NOS |
![Bendamustine Desmethyl Impurity](/CAS/20180906/GIF/41515-13-3.gif) |
Bendamustine Desmethyl Impurity |
41515-13-3 |
C15H19Cl2N3O2 |
![ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド)](/CAS/20150408/GIF/174227-14-6.gif) |
ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド) |
174227-14-6 |
C25H25N5O5S |
![BenzaMide, N-[1-(3,5-di-O-benzoyl-2-C-Methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyriMidinyl]-](/CAS/20180808/GIF/863329-62-8.gif) |
BenzaMide, N-[1-(3,5-di-O-benzoyl-2-C-Methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyriMidinyl]- |
863329-62-8 |
C31H27N3O8 |
![Fosfluconazole iMpurity](/) |
Fosfluconazole iMpurity |
|
|
![Cinacalcet Impurity D](/CAS/20180808/GIF/1271930-15-4.gif) |
Cinacalcet Impurity D |
1271930-15-4 |
C32H31F6N |
![BendaMustine Dihydroxy IMpurity](/CAS/20211123/GIF/109882-29-3.gif) |
BendaMustine Dihydroxy IMpurity |
109882-29-3 |
C16H24ClN3O4 |
![BroMocriptine IMpurity G](/CAS/20150408/GIF/CB62673659.gif) |
BroMocriptine IMpurity G |
|
C32H40BrN5O5 |
![Captopril IMpurity H](/CAS/20200611/GIF/205521-07-9.gif) |
Captopril IMpurity H |
205521-07-9 |
C15H23NO5S2 |
![(S)-Azelastine](/CAS/GIF/143228-85-7.gif) |
(S)-Azelastine |
143228-85-7 |
C22H24ClN3O |
![Relugolix Impurity 92](/) |
Relugolix Impurity 92 |
|
|
![N-Desethyl Vardenafil](/CAS/GIF/448184-46-1.gif) |
N-Desethyl Vardenafil |
448184-46-1 |
C21H28N6O4S |
![O-デスメチルゲフィチニブ](/CAS/GIF/847949-49-9.gif) |
O-デスメチルゲフィチニブ |
847949-49-9 |
C21H22ClFN4O3 |
![N-デメチルシルデナフィルピラゾール](/CAS/GIF/139755-95-6.gif) |
N-デメチルシルデナフィルピラゾール |
139755-95-6 |
C21H28N6O4S |
![S-(-)-Tolterodine](/CAS/GIF/124937-53-7.gif) |
S-(-)-Tolterodine |
124937-53-7 |
C22H31NO |
![ゾルミトリプタンN-オキシド](/CAS/GIF/251451-30-6.gif) |
ゾルミトリプタンN-オキシド |
251451-30-6 |
C16H21N3O3 |
![3-(hydroxymethyl)-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/) |
3-(hydroxymethyl)-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
|
![7-CHLORO-1,3DIHYDRO-5-FLUOROPHENYL-2-NITRO-METHYLENE-2H-1,4-BENZODIAZEPINE-4-OXIDE](/CAS/GIF/60656-76-0.gif) |
7-CHLORO-1,3DIHYDRO-5-FLUOROPHENYL-2-NITRO-METHYLENE-2H-1,4-BENZODIAZEPINE-4-OXIDE |
60656-76-0 |
C16H11ClFN3O3 |
![(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン](/CAS/GIF/80657-17-6.gif) |
(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン |
80657-17-6 |
C18H22O2 |
![2-デオキシテトロン酸](/CAS/GIF/1518-61-2.gif) |
2-デオキシテトロン酸 |
1518-61-2 |
C4H8O4 |
![シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]]](/CAS/GIF/59865-16-6.gif) |
シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]] |
59865-16-6 |
C62H111N11O12 |
![GINKGOLIC ACIDS](/) |
GINKGOLIC ACIDS |
|
|
![(R)-ズロキセチン塩酸塩](/CAS/GIF/910138-96-4.gif) |
(R)-ズロキセチン塩酸塩 |
910138-96-4 |
C18H20ClNOS |
![(R)-テラゾシン](/CAS/GIF/109351-34-0.gif) |
(R)-テラゾシン |
109351-34-0 |
C19H25N5O4 |
![(1S,4R)-4-アミノ-2-シクロペンテン-1-カルボン酸メチル](/CAS/GIF/138923-03-2.gif) |
(1S,4R)-4-アミノ-2-シクロペンテン-1-カルボン酸メチル |
138923-03-2 |
C7H11NO2 |
![L-Alanine,propylester(9CI)](/CAS/GIF/58989-06-3.gif) |
L-Alanine,propylester(9CI) |
58989-06-3 |
C6H13NO2 |
![N-hydroxyphenetidine](/CAS/GIF/38246-95-6.gif) |
N-hydroxyphenetidine |
38246-95-6 |
|
![1-エチル-3-カルボキシ-6-フルオロ-1,4-ジヒドロ-7-(4-メチルピペラジノ)-4-オキソキノリン1-オキシド](/CAS/GIF/85145-21-7.gif) |
1-エチル-3-カルボキシ-6-フルオロ-1,4-ジヒドロ-7-(4-メチルピペラジノ)-4-オキソキノリン1-オキシド |
85145-21-7 |
C17H20FN3O4 |
![2,3-ジメチル-1,4-ナフトキノン](/CAS/GIF/2197-57-1.gif) |
2,3-ジメチル-1,4-ナフトキノン |
2197-57-1 |
C12H10O2 |
![[(1-エチルピペリジン-3-イル)メチル]アミン](/CAS/GIF/102459-02-9.gif) |
[(1-エチルピペリジン-3-イル)メチル]アミン |
102459-02-9 |
C8H18N2 |
![8-ヒドロキシミルタザピン](/CAS/GIF/102335-57-9.gif) |
8-ヒドロキシミルタザピン |
102335-57-9 |
C17H19N3O |
![Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B))](/CAS/20211123/GIF/178949-04-7.gif) |
Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B)) |
178949-04-7 |
C13H15N5O4S2 |
![Ceftriaxone IMpurit D](/) |
Ceftriaxone IMpurit D |
|
|
![Ciprofloxacin Related CoMpound](/CAS/20180808/GIF/528851-30-1.gif) |
Ciprofloxacin Related CoMpound |
528851-30-1 |
C15H17Cl2N3O3 |
![Dasatinib IMpurity 4](/) |
Dasatinib IMpurity 4 |
|
|
![Deferasirox Methyl Ester](/CAS/20180906/GIF/1266741-05-2.gif) |
Deferasirox Methyl Ester |
1266741-05-2 |
C22H17N3O4 |
![酢酸Δコルチンエン](/CAS/GIF/4380-55-6.gif) |
酢酸Δコルチンエン |
4380-55-6 |
C23H28O5 |
![Entecavir IMpurity A](/) |
Entecavir IMpurity A |
|
|
![Fasudil IMpurity 1](/CAS/20200515/GIF/1423155-03-6.gif) |
Fasudil IMpurity 1 |
1423155-03-6 |
C14H17N3O2S |
![Irbesartan IMpurity](/CAS/20150408/GIF/CB62674535.gif) |
Irbesartan IMpurity |
1079997-01-5 |
C26H30N6O2 |
![Montelukast EP IMpurity I](/) |
Montelukast EP IMpurity I |
|
|
![RaceMic Fudosteine HCl](/CAS/20200611/GIF/1023971-15-4.gif) |
RaceMic Fudosteine HCl |
1023971-15-4 |
C6H13NO3S |
![RocuroniuM BroMide IMpurity 18](/) |
RocuroniuM BroMide IMpurity 18 |
|
|
![SalMeterol IMpurity E](/CAS/20150408/GIF/CB62675648.gif) |
SalMeterol IMpurity E |
|
C25H37NO4 |
![SulbactaM IMpurity C](/) |
SulbactaM IMpurity C |
|
|
![1-[4-(4-アミノ-6,7-ジメトキシ-2-キナゾリニル)-1-ピペラジニル]-2-ヒドロキシ-1-ペンタノン](/CAS/GIF/152551-75-2.gif) |
1-[4-(4-アミノ-6,7-ジメトキシ-2-キナゾリニル)-1-ピペラジニル]-2-ヒドロキシ-1-ペンタノン |
152551-75-2 |
C19H27N5O4 |
![Ticarcillin SodiuM IMpurity A](/CAS/20211123/GIF/36041-93-7.gif) |
Ticarcillin SodiuM IMpurity A |
36041-93-7 |
C14H16N2O4S2 |
![EthanediaMide iMpurity E](/CAS/20150408/GIF/CB62676933.gif) |
EthanediaMide iMpurity E |
|
C2H4N2O2 |
![Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate](/CAS/20150408/GIF/1206875-41-3.gif) |
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate |
1206875-41-3 |
C15H22N2O2 |
![S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine](/CAS/20150408/GIF/889443-69-0.gif) |
S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine |
889443-69-0 |
C11H17NO |
![N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide](/CAS/20150408/GIF/CB62685166.gif) |
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide |
855860-75-2 |
C9H11ClN2O |
![Ibrutinib iMpurity](/CAS/20211123/GIF/936351-48-3.gif) |
Ibrutinib iMpurity |
936351-48-3 |
C12H13ClN2O |
![1-フェニル-5-(ピリジン-2-イル)-1,2-ジヒドロピリジン-2-オン](/CAS/GIF/381725-50-4.gif) |
1-フェニル-5-(ピリジン-2-イル)-1,2-ジヒドロピリジン-2-オン |
381725-50-4 |
C16H12N2O |
![(1R,5S,6R)-REL-5-(1-エチルプロポキシ)-7-オキサビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸エチルエステル](/CAS/GIF/347378-74-9.gif) |
(1R,5S,6R)-REL-5-(1-エチルプロポキシ)-7-オキサビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸エチルエステル |
347378-74-9 |
C14H22O4 |
![(3R,5R,6E)-7-[2-シクロプロピル-4-(4-フルオロフェニル)-3-キノリニル]-3,5-ジヒドロキシ-6-ヘプテン酸カルシウム塩](/CAS/GIF/254452-96-5.gif) |
(3R,5R,6E)-7-[2-シクロプロピル-4-(4-フルオロフェニル)-3-キノリニル]-3,5-ジヒドロキシ-6-ヘプテン酸カルシウム塩 |
254452-96-5 |
C25H24FNO4 |